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Background: The dietary supply of methyl donors such as folate, vitamin B12, betaine, methionine, and choline is
essential for normal growth, development, and physiological functions through the life course. Both human and
animal studies have shown that vitamin B12 deficiency is associated with altered lipid profile and play an important role
in the prediction of metabolic risk, however, as of yet, no direct mechanism has been investigated to confirm this.
Results: Three independent clinical studies of women (i) non-pregnant at child-bearing age, (ii) in early pregnancy,
and (iii) at delivery showed that low vitamin B12 status was associated with higher total cholesterol, LDL cholesterol,
and cholesterol-to-HDL ratio. These results guided the investigation into the cellular mechanisms of induced cholesterol
biosynthesis due to vitamin B12 deficiency, using human adipocytes as a model system. Adipocytes cultured in low or
no vitamin B12 conditions had increased cholesterol and homocysteine levels compared to control. The induction of
cholesterol biosynthesis was associated with reduced s-adenosylmethionine (AdoMet)-to-s-adenosylhomocysteine
(AdoHcy) ratio, also known as methylation potential (MP). We therefore studied whether reduced MP could lead to
hypomethylation of genes involved in the regulation of cholesterol biosynthesis. Genome-wide and targeted DNA
methylation analysis identified that the promoter regions of SREBF1 and LDLR, two key regulators of cholesterol
biosynthesis, were hypomethylated under vitamin B12-deficient conditions, and as a result, their expressions
and cholesterol biosynthesis were also significantly increased. This finding was further confirmed by the
addition of the methylation inhibitor, 5-aza-2′-deoxycytidine, which resulted in increased SREBF1 and LDLR
expressions and cholesterol accumulation in vitamin B12-sufficient conditions. Finally, we observed that the
expression of SREBF1, LDLR, and cholesterol biosynthesis genes were increased in adipose tissue of vitamin
B12 deficient mothers compared to control group.
Conclusions: Clinical data suggests that vitamin B12 deficiency is an important metabolic risk factor. Regulation
of AdoMet-to-AdoHcy levels by vitamin B12 could be an important mechanism by which it can influence cholesterol
biosynthesis pathway in human adipocytes.
Keywords: Vitamin B12, Folic acid, Cholesterol, Homocysteine, Adipocyte, Methylation* Correspondence: p.saravanan@warwick.ac.uk; g.tripathi@warwick.ac.uk
1Division of Metabolic and Vascular Health, Clinical Sciences Research
Laboratories, Warwick Medical School, University Hospital Coventry and
Warwickshire, University of Warwick, Clifford Bridge Road, Coventry CV2
2DX, UK
7iDEA Centre, George Eliot Hospital, Nuneton CV10 7DJ, UK
Full list of author information is available at the end of the article
© 2015 Adaikalakoteswari et al.; licensee BioM
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.ed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Adaikalakoteswari et al. Clinical Epigenetics  (2015) 7:14 Page 2 of 14Background
Adipose tissue (AT) plays a central role in integrating
energy metabolism and glucose homeostasis [1]. Besides
being the major site of fatty acid storage as triglycerides
(TG), AT is also the body’s largest cholesterol pool. In
AT, nearly all cholesterol (>95%) exists as free, non-
esterified form and resides in the plasma membrane or
at the cytosolic interface of lipid droplets [2-4]. In con-
trast, other specialised cells and tissues store small pools
of esterified cholesterol, such as adrenal cells or foam
cells, which have the capacity to accumulate consider-
able quantities of excess cholesterol esters [5]. A delicate
balance exists between uptake, synthesis, and storage
which tightly controls the abundance of free cholesterol
in peripheral cells [6] while excess free cholesterol is in
fact deleterious to cells [7]. AT from ob/ob mice exhibits
an increase in cholesterol biosynthesis [8], and hypertro-
phied adipocytes from obesity rodent model, Zucker rats
have elevated mRNA expression of SREBP-2, 3-hydroxy-
3-methylglutaryl-CoA reductase (HMGCR), and the
LDL receptor (LDLR) [9,10]. Studies in Zucker rats [11]
and 3T3F442A cells [12] also highlight that with an in-
crease in triglyceride storage, cholesterol is redistributed
from the plasma membrane to the surface of the lipid
droplet and adipocyte cholesterol levels appear to in-
crease in proportion to the triglyceride content [13].
There is also accumulating evidence that adipose choles-
terol imbalance is closely associated with adipocyte dys-
function and obesity-mediated metabolic complications
and insulin resistance [9,13,14].
Despite the significant physiological importance of adi-
pocyte cholesterol, especially with regard to the reported
association between obesity and mortality from cardio-
vascular diseases [15], the regulation of de novo synthetic
pathway of cholesterol within adipocytes has not been
studied in detail. Kumar et al. [16] demonstrate that in
Wistar rats, offspring from vitamin B12 (B12) deficient
mothers had higher adiposity and altered lipid metabol-
ism and hypothesised that this could be due to dysfunc-
tional adipocyte. These offspring had higher total
cholesterol, triglycerides, IL-6, and TNF-α and had lower
adiponectin and leptin compared with control offspring.
In a prospective, longitudinal study of humans in early
pregnancy, vitamin B12 deficiency independently pre-
dicted gestational diabetes and type 2 diabetes (T2D) at
5-year post-delivery. This reported association was medi-
ated through adiposity highlighting the potential role of
low vitamin B12-induced adipocyte dysfunction [17].
Furthermore, maternal vitamin B12 deficiency also pre-
dicted insulin resistance in a 6-year-old offspring, sug-
gesting a role in foetal programming [18]. The vitamins
folic acid, B12, B6, and B2 participate in one carbon me-
tabolism as source of coenzymes. One carbon metabol-
ism is a network of interrelated biochemical pathwaysthat donate and regenerate one-carbon units, including
the methyl group (reviewed [19,20]). Vitamin B12 functions
as a coenzyme for 5-methyltetrahydrofolic acid (MTHF)-
dependent methionine synthase (MS) which catalyses
the synthesis of methionine from homocysteine [21,22].
Methionine is then converted to s-adenosylmethionine
(AdoMet), a universal methyl group donor for methylation
of DNA and RNA [23].
Restriction of methyl donors, including vitamin B12
and folate in pregnant sheep increases offspring’s meta-
bolic risk, likely mediated by altered DNA methylation
[24]. In metazoans, low levels of methyl donor AdoMet
and phosphatidylcholine activate SREBP-1 and induce
lipogenesis [25]. Both vitamin B12 and folic acid play im-
portant roles in regulating the levels of AdoMet and
homocysteine [26,27]. In the current study, we investi-
gated the potential clinical relevance on circulating lipid
profiles utilising the data from two different cohorts: the
British National Diet and National Survey (NDNS), and
women subjects from Saudi Arabian population and
found significant associations between cholesterol, tri-
glycerides, and vitamin B12 deficiency. Therefore, this
current study was designed to understand the molecular
mechanisms of how vitamin B12 restriction may be indu-
cing these effects. We used human adipocytes as the
model system and show that vitamin B12 restriction in-
duced cholesterol biosynthesis in adipocytes by limiting
cellular AdoMet levels and modulating the methylation
of genes which regulate cholesterol biosynthesis. This
was further confirmed in human adipose tissue obtained
from vitamin B12 deficient and sufficient women under-
going caesarean section.
Results
Association of low vitamin B12 and lipid profile in clinical
studies
Our interest was to investigate the association between
vitamin B12 and lipid profile in the women of reproduct-
ive age and/or during pregnancy due to the potential
relevance to the offspring. We had access to the two co-
horts which fulfilled the criteria: (1) NDNS, a publically
available dataset from the UK and (2) pregnant women
from Saudi Arabia.
NDNS
In NDNS survey, 1,256 subjects had full biochemical
analysis which included lipid profiles, B12, folic acid, and
homocysteine. Three hundred fifteen women were of
reproductive age (19 to 39 years). The prevalence of
serum vitamin B12 insufficiency (<148 pmol/L) was 12%.
Women with low B12 had significantly higher choles-
terol, LDL cholesterol, cholesterol-to-HDL ratio, and
homocysteine than normal B12 women. The BMI was
similar in both groups (Table 1).
Table 1 Clinical characteristics of child bearing group (female 19 to 39 years) from NDNS and pregnant women from
Saudi population
NDNS Saudi cohort
Total B12 (ng/L) Total Maternal B12 (ng/L)
n = 315 >190 (n = 278) ≤190 (n = 37) n = 152 >190 (n = 84) ≤190 (n = 68)
Age (years) 31.2 ± 0.32 31.7 ± 0.34 30.5 ± 0.94 28.6 ± 0.43 28.5 ± 0.59 28.5 ± 0.62
BMI (kg/m2) 25.3 ± 0.29 25.2 ± 0.30 26.3 ± 1.0 26.75 ± 0.43 26.0 ± 0.55 27.8 ± 0.66*
WHR 0.77 ± 0.003 0.77 ± 0.003 0.79 ± 0.01 - - -
Total-C (mmol/L) 4.84 ± 0.06 4.79 ± 0.06 5.20 ± 0.21* 5.98 ± 0.09 5.80 ± 0.12 6.20 ± 0.15*
LDL-C (mmol/L) 3.58 ± 0.06 3.52 ± 0.06 4.01 ± 0.21** 3.02 ± 0.14 2.99 ± 0.18 3.14 ± 0.21
HDL-C (mmol/L) 1.26 ± 0.02 1.27 ± 0.02 1.19 ± 0.06 1.25 ± 0.03 1.25 ± 0.04 1.24 ± 0.04
Total-C:HDL ratio 4.11 ± 0.08 4.03 ± 0.08 4.70 ± 0.26** 5.11 ± 0.14 4.99 ± 0.18 5.29 ± 0.22
TG (mmol/L) - - - 1.77 ± 0.05 1.64 ± 0.06 1.93 ± 0.07**
Folate (μg/L) 9.24 ± 0.21 9.35 ± 0.23 8.46 ± 0.51 10.4 ± 0.34 10.4 ± 0.49 10.5 ± 0.46
Homocysteine (μmol/L) 9.98 ± 0.21 9.78 ± 0.21 11.53 ± 0.65** 4.74 ± 0.13 4.45 ± 0.17 5.11 ± 0.21*
P value compared to B12 (>190 ng/L) group; *P < 0.05; **P < 0.01. Continuous variables are mean ± SEM.
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A cohort of 152 pregnant women living in Riyadh,
KSA, participated in an observational study designed
to assess the B12, folate, and homocysteine status
during pregnancy. The data collection was carried out
from pregnant women at the second trimester: be-
tween 16 to 28 weeks gestation. The prevalence of
serum B12 insufficiency (<148 pmol/L) was 45%. Com-
pared to normal B12 women, low B12 women had
significantly higher BMI, cholesterol, triglycerides, and
homocysteine than normal B12 women (Table 1).
In addition, B12 independently predicted cholesterol
(β = −0.150; P < 0.001) and triglycerides (β = −0.201;
P = 0.005) after adjusting for age and BMI in multiple
regression analysis. B12 explained 7.5% (P = 0.001) ofFigure 1 Regression coefficient of vitamin B12 with (A) cholesterol an
statistical comparisons. Model included B12, age, and BMI.the variation in cholesterol and 7.4% (P = 0.005) of the
variation in triglycerides (Figure 1A and B).
Low vitamin B12 induces cholesterol biosynthesis in
human adipocytes
Human preadipocytes were cultured and fully differenti-
ated in 12 different conditions representing varying
concentrations of B12 and folic acid and intracellular
cholesterol and extracellular homocysteine were mea-
sured. Adipocytes cultured in low (LB) or no B12 (NoB)
media showed maximum and significant increase in total
cholesterol and homocysteine levels compared with con-
trols (Additional file 1: Figure S1 A and B). Folic acid
alone had no significant effect on cholesterol and homo-
cysteine levels. Therefore, we designed experiments tod (B) triglycerides in pregnant women. *Log-transformed for
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concentration constant to 6 μM for rest of the experi-
ments and used three main conditions: (1) control (500
nM B12 represented adequate B12), (2) LB (0.15 nM B12
represented B12 deficiency) and (3) NoB (0 nM B12 rep-
resented extreme B12 deficiency). The total cholesterol
was significantly increased in NoB and LB conditions
compared to control (Figure 2A).
Expression of cholesterol biosynthesis genes was
measured by qRT-PCR. In the first fundamental step,
mevalonate formation from acetyl CoA, the expression
of 3-hydroxy-3-methylglutaryl-CoA synthetase (HMGCS1)
(Figure 2B; P < 0.001) and the rate limiting enzyme,
3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR)
(Figure 2C; P < 0.01) was significantly upregulated in NoB
and LB condition compared to control. Similarly, the other
downstream steps of this pathway showed the same pattern
of significant gene expression changes. The other genes
studied were isopentenyl diphosphate isomerase (IDI1),
squalene epoxidase (SQLE) and methylsterol mono-
oxygenase (SC4MOL) (Figure 2D,E,F; all P < 0.01).A B
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Figure 2 Effect of vitamin B12 on cholesterol biosynthesis. (A) Total chol
B12), LB (0.15 nM B12), and NoB (0 nM B12). Total cholesterol was normalized fo
cholesterol biosynthesis genes in adipocytes. (B) HMGCS1, (C) HMGCR, (D) ID
triplicates. Values are mean ± SEM. *P≤ 0.05; **P≤ 0.01, ***P≤ 0.001, P value cLow vitamin B12 induces expression of cholesterol
synthesis and transport regulators
The sterol regulatory element-binding protein (SREBP-1
and 2) transcription factors and LDLR play a critical role
in regulating cholesterol quantity. Protein as well as
mRNA expressions of both SREBPs was significantly
upregulated in NoB and LB conditions compared with
control (Figure 3A,B,C; P < 0.05). The LDLR mRNA ex-
pression was also significantly higher in LB and NoB
conditions compared with control (Figure 3D). The
mRNA expression of other regulatory genes; insulin in-
duced gene 1 (INSIG1) and StAR-related lipid transfer
protein 4 (StarD4) was also significantly upregulated in
both NoB and LB conditions compared to control
(Figure 3E,F; both P < 0.01).
SREBF1 and LDLR genes are hypomethylated in low
vitamin B12 condition
Vitamin B12 plays an important role in regulating AdoMet
levels which has been shown to regulate the SREBF1
expression [25]. AdoMet is the methyl donor and isLB NoB
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Figure 3 Effect of vitamin B12 on regulation of cholesterol biosynthesis. Protein and/or mRNA expression of genes regulating cholesterol
biosynthesis in adipocytes. (A) SREBP-1, (B) SREBP-2, (C) SREBF1 and SREBF2, (D) LDLR, (E) INSIG1 and (F) StarD4. All experiments were performed
as triplicates. Values are mean ± SEM. *P ≤ 0.05; **P ≤ 0.01, ***P ≤ 0.001, P value compared to control.
Adaikalakoteswari et al. Clinical Epigenetics  (2015) 7:14 Page 5 of 14responsible for methylation of DNA, protein, and lipids;
we hypothesised that the upregulation of cholesterol syn-
thesis in low B12 conditions could be due to altered
methylation of genes regulating cholesterol biosynthesis.
Therefore, we interrogated data from our genome-wide
study to generate quantitative levels of DNA methylation
at SREBF1, SREBF2, and LDLR.
Of the genes identified from the genome-wide data-
set, probes at two targets; SREBF1 and LDLR showed
differential methylation (reaching genome-wide sig-
nificance) across experimental groups. The SREBF1
probe (cg27407935; chr17:17723235) showed a quanti-
tative decrease in DNA methylation across from the
control to LB to NoB, with mean β values for sample
triplicates as follows: control, 0.47; LB, 0.41; NoB, 0.40
(F = 85.8, P value < 0.0001) (Figure 4A). This probe lies
within the gene body of SREBF1 at a DNAse I hyper-
sensitivity site and RNA Pol2 binding site (suggested
by ENCODE data), suggesting a putative role in tran-
scriptional regulation. (Additional file 1: Figure S4A).
The LDLR probe (cg22971501; chr19:11199476) also
showed relative hypomethylation across LBF and NoB
with corresponding mean β values of 0.65, 0.61, and 0.60
(F = 14.41, P value < 0.0001) (Figure 4B). The LDLR probelays 1,500 bp upstream of the 5′UTR at the gene promoter
(Additional file 1: Figure S4B). For both SREBF1 and
LDLR genes, the hypomethylation sites are close to the
transcription start site (TSS) and are located near binding
sites for PPARγ and C/EBPα (Additional file 1: Figure S4
A and B). These binding sites have been obtained from
ChIP-seq data published elsewhere [28,29]. There was no
significant difference in the mean beta values at SREBF2.
Validation experiments, using BS-pyrosequencing, con-
firmed the differential methylation at SREBF1 and LDLR
between the experimental groups at the CpG sites defined
by the methylation array probes. Mean methylation values
for SREBF1 were as follows: control, 0.15; LB, 0.13; NoB,
0.13 (ANOVA, P value < 0.0001) (Figure 4C; Additional
file 2: Table S3). Mean methylation values for LDLR were
as follows: control, 0.42; LB, 0.38; NoB, 0.39 (ANOVA,
P value < 0.0001) (Figure 4D; Additional file 2: Table S4).
Between-group methylation differences validate those
identified using the Illumina 450k array at the same
CpG; the range of methylation values varies between
BS-pyrosequencing and Illumina probe data due to the lat-
ter undergoing genome-wide normalisation and process-
ing. The mRNA expression of both SREBF1 and LDLR
was significantly increased in the LB and NoB conditions
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Figure 4 Effect of vitamin B12 on methylation of cholesterol regulatory genes. Genome-wide DNA methylation analysis of cholesterol
regulatory genes was performed in adipocytes cultured in customised media, control, LB, and NoB. (A) SREBF-1 and (B) LDLR from Illumina.
Validation by BS-pyrosequencing was also done in the same samples and methylation status confirmed for (C) SREBF-1 and (D) LDLR. All
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were hypomethylated.
Vitamin B12 deficiency lowers AdoMet/AdoHcy
To test whether vitamin B12 deficiency impairs the cellu-
lar methylation potential (AdoMet/AdoHcy), intracellu-
lar AdoMet and AdoHcy were determined (Figure 5A,
B). AdoMet and AdoHcy are the substrate and product
of essential methyltransferase reactions. We found that
adipocytes treated in B12 deficient conditions showed
significantly decreased AdoMet, increased AdoHcy, and
decreased AdoMet/AdoHcy (Figure 5C). A decrease in
AdoMet/AdoHcy is predictive of reduced methylation
potential (MP) and confirms that DNA methylation is
likely to be affected in adipocytes cultured in deficient
B12 conditions.Inhibition of methylation by 5-Aza-dC induces cholesterol
biosynthesis but not homocysteine in high vitamin B12
condition
To further confirm that hypomethylation of SREBF1 and
LDLR is the key mechanism by which cholesterol bio-
synthesis in human adipocytes is increased, we treated
adipocytes with B12 in the presence of methylation
inhibitor, 200 nM 5-Aza-dC (control + 5-Aza-dC). We
observed that adipocytes treated with 5-Aza-dC showed
significantly increased cholesterol accumulation com-
pared to control (Figure 6A). There was no change in
homocysteine levels under the same conditions (Figure 6B).
This confirms that the increased cholesterol biosynthesis in
B12-deficient conditions was due to reduced AdoMet/
AdoHcy which resulted in hypomethylation of SREBF1
and LDLR. The expression of cholesterol biosynthetic gene
05
10
15
20
25
30
Control LB NoB
A
d
o
M
et
(p
m
o
lp
er
 1
x1
06
 c
el
ls
)
AdoMet
***
***
0
5
10
15
Control LB NoB
A
d
o
H
cy
(p
m
o
lp
er
 1
x1
06
 c
el
ls
)
AdoHcy
****
0
1
2
3
4
Control LB NoB
A
d
o
M
et
:A
d
o
H
cy
AdoMet:AdoHcy
***
***
A B C
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(SREBF1 and LDLR) (Figure 6C,D) was also significantly
increased in NoB and control + 5-Aza-dC compared to
control.
B12 deficiency induces expression of cholesterol biosynthesis
genes in human adipose tissue (UHCW cohort)
The prevalence of serum B12 deficiency in this cohort of
pregnant women at the time of delivery was 39.6%. Low
B12 mothers had significantly higher BMI, cholesterol,
LDL cholesterol, triglycerides, and homocysteine than
normal B12 mothers (Table 2). To validate the findings
from our cultured primary human adipocytes, we further
performed the key experiments in maternal subcuta-
neous adipose tissue (ScAT) chosen from normal B12
(n = 5) and low B12 (n = 5) mothers. We observed that
the mRNA expressions of cholesterol regulatory genes;
SREBF1, SREBF2 and LDLR (Figure 7A,B,C), and
cholesterol biosynthetic gene; and HMGCR (Figure 7D)
were upregulated in adipose tissue from low B12 mothers
compared to normal B12 mothers (Figure 7).
Effect of vitamin B12 in primary human adipocytes
In order to validate the findings from human adipocyte
cell line ChubS-7, the key experiments were also per-
formed in cultured primary human adipocytes under the
same conditions. The total cholesterol as well as homo-
cysteine was significantly increased in primary adipocytes
in the LB and NoB conditions compared with control
(Additional file 1: Figure S5 A and B). The mRNA expres-
sions of genes regulating cholesterol biosynthesis, SREBF1
and SREBF2, and LDLR were also significantly increased
(Additional file 1: Figure S5 C, D, and E).
Discussion
The dietary supply of the methyl donors folic acid, vita-
min B12, betaine, methionine, and choline is essential fornormal growth, development, and physiological func-
tions through the life course [19,30]. Both human
[18,22,31,32] and animal [16] studies have shown that
vitamin B12 deficiency is associated with altered lipid
profile and metabolic disorder, and it has been hypothe-
sized that this may be due DNA methylation changes.
The results of the present study provide novel evidence
that vitamin B12 plays a vital role in the biosynthesis of
cholesterol through induction of SREBPs expression in
human adipocytes and DNA hypomethylation due to
limited availability of AdoMet. Specifically, we have
demonstrated that low vitamin B12 (a) is associated and
independently predicted higher total cholesterol, LDL
cholesterol, and cholesterol-to-HDL ratio in serum; (b)
induced cholesterol biosynthesis and homocysteine in
adipocytes; (c) increased expression of SREBPs and
genes responsible for cholesterol biosynthesis; (d) re-
duced AdoMet-to-AdoHcy levels and caused hypome-
thylation of SREBF1 and LDLR genes in their regulatory
regions leading to increased mRNA expression; and (e)
increased expression of SREBs, LDLR, and HMGCR in
human adipose tissue.
Cholesterol is a vital component of all mammalian
cells, and it is essential for normal functioning of the
body; each cell synthesizes it from simpler molecules, a
complex 37-step process that starts with the intracellular
protein enzyme HMG-CoA reductase (HMGCR). How-
ever, high levels of cholesterol in the blood circulation,
depending on how they are transported within lipopro-
teins, are strongly associated with increased risk of
cardiovascular diseases (CVD) [33]. The causes of why
some people are at higher risk of cholesterol dysregula-
tion is not clear. Our study using three independent
clinical cohorts: women at child bearing age, during
early pregnancy, and at delivery shows that low vitamin
B12 status was associated with higher total cholesterol,
LDL cholesterol, and cholesterol-to-HDL ratio (Tables 1
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media. Relative mRNA expression of (C) SREBF1, (D) LDLR, and (E) HMGCR were measured in adipocytes maintained in customised media control,
NoB, and control + 5-Aza-dC. 5-Aza-dC is methylation inhibitor. All experiments were performed as triplicates. Values are mean ± SEM. *P ≤ 0.05;
**P ≤ 0.01, ***P ≤ 0.001, P value compared to control.
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type 2 diabetes found that vitamin B12 deficiency was as-
sociated with adverse lipid profile [34]. The first direct
evidence that vitamin B12 deficiency could lead to ad-
verse lipid profile has come from an in vivo study in
Wistar rats [16] that showed offspring from vitamin B12-
deficient mothers had higher adiposity and altered lipid
metabolism. The authors of this study hypothesized that
this was due to altered and dysfunctional adipocytes and
showed that offspring from B12-deficient mothers had
higher total cholesterol, triglycerides, IL-6, and TNF-α
and had lower adiponectin and leptin compared with
control offspring. To investigate the possible mecha-
nisms underlying the findings of Kumar et al. [16], we
chose human preadipocytes as model system as these
cells undergo several population doublings before differ-
entiation, mimicking the inter-generational effect in
in vitro conditions. Upon investigation, we observed thatthe total intracellular cholesterol as well as extracellular
homocysteine were significantly increased in low (LB)
and no vitamin B12 (NoB) conditions, while folic acid
levels had no significant effect either on homocysteine
levels or on cholesterol (Additional file 1: Figure S1 A
and B; Figure 1A). Though these pathways have previ-
ously been linked to hyperhomocysteinemia (HyHcy)
[35], our data shows that low vitamin B12 independently
contributes to both HyHcy and dysregulation of choles-
terol synthesis. This provides the first mechanistic data
in support of recent human cohort studies that identify
an inverse relationship between vitamin B12 status and a
phenotype of adiposity, gestational diabetes, T2D, and
insulin resistance [17,18]. While the findings of these co-
horts are only associations, a plausible causal biochem-
ical mechanism is now proposed that can be explored
further in longitudinal and intervention-based clinical
studies.
Figure 7 Effect of vitamin B12 on human adipose tissue ex vivo.
mRNA expression of genes regulating cholesterol biosynthesis in
adipocytes; (A) SREBF1, (B) SREBF2, (C) LDLR, and (D) HMGCR. Each
group was a minimum of n = 5. Values are mean ± SEM. *P ≤ 0.05;
**P ≤ 0.01, ***P ≤ 0.001, P value compared to control.
Table 2 Clinical characteristics of UHCW cohort
UHCW cohort Total Maternal B12 (ng/L)
n = 91 >190 (n = 55) ≤190 (n = 36)
Age (years) 32.7 ± 0.62 33.0 ± 0.84 32.3 ± 0.93
BMI (kg/m2) 29.4 ± 0.65 28.4 ± 0.82 30.8 ± 1.07*
Triglycerides (mmol/L) 2.69 (2.62, 3.06) 2.49 (2.37, 2.93) 3.04 (2.82, 3.48)*
Cholesterol (mmol/L) 6.48 (6.31, 6.89) 6.23 (5.99, 6.72) 6.86 (6.51, 7.43)*
LDL cholesterol (mmol/L) 3.53 (3.46, 3.95) 3.29 (3.16, 3.82) 3.91 (3.67, 4.38)*
HDL cholesterol (mmol/L) 1.56 (1.53, 1.72) 1.61 (1.54, 1.80) 1.49 (1.42, 1.70)
HOMA-IR 2.14 (2.47, 3.39) 1.87 (2.18, 3.51) 2.65 (2.45, 3.68)
Leptin (μg/L) 30.8 (32.3, 40.8) 29.3 (29.7, 40.6) 33.1 (31.3, 45.5)
Folate (μg/L) 10.5 (10.9, 13.2) 11.7 (11.5, 14.6) 9.0 (8.5, 12.4)*
Homocysteine (μmol/L) 6.23 (6.02, 7.54) 5.50 (5.26, 6.18) 7.53 (6.69, 10.11)**
Continuous variables are mean ± SEM or geometric mean (95% CI).
P value compared to maternal B12 (>190 ng/L) group; *P < 0.05; **P < 0.001.
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was investigated in detail and all the genes analyzed
(Figure 2) were upregulated under vitamin B12-deficient
conditions. The physiology of cholesterol and regulation
has been reviewed elsewhere [7,36,37]. Most of the genes
involved in cholesterol synthesis and transport are direct
target of SREBPs. Activation of SREBPs is critical as they
directly induce the expression of more than 30 genes
dedicated to the synthesis, uptake, and control of the
intracellular accumulation of cholesterol [6]. In this
study, we observed that the protein and mRNA expres-
sions of both SREBPs were significantly increased in
vitamin B12-deficient conditions. Regulation of choles-
terol biosynthesis is complex, and we observed increased
expression of other regulatory genes under the same
conditions, LDLR, INSIG1, and StarD4. LDLR along
with SREBP’s plays a critical role in regulating the
amount of cholesterol (Figure 3). The INSIG1 encodes
an ER membrane protein that plays a critical role in
regulating cholesterol concentrations in cells and dir-
ectly interacts with SREBP2 [38,39]. StarD4 has specific-
ally been linked to the movement of cholesterol to the
ER [40]. Increases in levels of either SREBP-1 or SREBP2
increases StarD4 levels in mouse liver, and increased
StarD4 increases active SREBP2 levels [41].
The close relationship of B12, folic acid, and homocyst-
eine in the one-carbon cycle plays an important role in
regulating the levels of AdoMet and AdoHcy [26,27].
AdoMet is used in the methylation of DNA, RNA, pro-
teins, phospholipids, and a number of other small mole-
cules and the ratio between AdoMet and AdoHcy may
be crucial in this process (reviewed [26]). Using TCblR/
CD320 knockout mice, Fernandez-Roig et al. [23] have
shown that vitamin B12 deficiency led to DNA hypomethy-
lation in the brain. We observed that the two cholesterol
regulating genes, SREBF1 and LDLR, were significantly
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tured in low or no B12 media compared with the cells cul-
tured control media which has high B12 (Figure 4). Walker
et al. [25] have noted that restricting AdoMet caused in-
creased SREBP1-dependent transcription and lipid accu-
mulation. We measured the AdoMet-to-AdoHcy ratio and
found it to be significantly lower in LB and NoB condition
compared with controls confirming the restricted availabil-
ity of AdoMet in a B12-deficient environment (Figure 5).
The AdoMet-to-AdoHcy ratio is known as a marker of
DNA MP due its direct relationship to the availability of
methyl groups capable of methylation. We confirmed DNA
hypomethylation in these conditions in both SREBF1 and
LDLR, and that the sites of hypomethylation were close to
the TSS and were located near binding sites for PPARγ and
C/EBPα, master regulators of lipogenesis and adipocyte
differentiation (Additional file 1: Figure S4 A and B). These
binding sites in human adipocytes were obtained from
ChIP-seq study published by Mikkelsen et al. [28].
The significance of this observation was further en-
hanced as the mRNA expression, of these two genes,
were also increased under the same conditions. This is
one of the first observations where gene specific
altered methylation has been observed due to specific
nutrient deficiency in a human cell type.
To confirm that cholesterol biosynthesis was induced
due to change in methylation status of SREBF1 and
LDLR in B12 restricted conditions, we cultured adipo-
cytes in control media with methylation inhibitor 5-Aza-
dC and measured total cholesterol and homocysteine.
Interestingly, the total cholesterol was higher in control +
5-Aza-dC cells compared to control (Figure 6A), similar
to cells cultured in NoB condition but found that
methylation inhibition had no effect on homocysteine
levels (Figure 6B). The mRNA expression of SREBF1,
LDLR, and HMGCR was also significantly increased in
the control + 5-Aza-dC condition compared with con-
trol (Figure 6C,D,E). This further confirmed that the in-
creased cholesterol biosynthesis in vitamin B12-deficient
conditions was due to reduced AdoMet/AdoHcy levels,
not high homocysteine, resulting in hypomethylation of
SREBF1 and LDLR. To further confirm the effect of
vitamin B12 in cholesterol biosynthesis ex vivo, we used
human adipose tissue from vitamin B12 deficient and
sufficient mothers undergoing caesarean section. Intri-
guingly, we found that the gene expressions of choles-
terol regulatory genes (SREBF1, SREBF2, LDLR) and
cholesterol biosynthetic gene HMGCR were significantly
upregulated in low vitamin B12 group compared to control
(Figure 7). In the same cohort, low vitamin B12 women
had significantly higher BMI, cholesterol, LDL cholesterol,
triglycerides, and homocysteine than normal vitamin B12
women (Table 2), supporting the findings of Kumar et al.
[16] in their animal model. Our human data suggestthat vitamin B12 deficiency could alter certain pathways
and may play an important role in predicting future
metabolic risk.
Adipose tissue is the largest pool of free cholesterol in
the body [42,43]. In rats, a decreased intracellular chol-
esterol content and simultaneous increase in LDL-C
levels have been observed under fasting conditions
[4,42,44,45]. In contrast, an elevation of the adipocyte
cholesterol amount has also been reported in obese
rodents and humans [43,46] and studies using ob/ob
mice show increased HMGCR activity in adipose (but not
liver) and higher plasma cholesterol in young obese mice
compared to control littermates, suggesting an adipocyte-
specific regulation of cholesterol metabolism in obesity
[8,47]. Our clinical observations show strong associations
of vitamin B12 deficiency with BMI, triglycerides, and total
cholesterol, and our in vitro studies in adipocytes show
that vitamin B12-deficient conditions induce de novo
cholesterol biosynthesis. Studies have also highlighted a
strong association between adipocyte cholesterol content
and fat cell size and triglyceride content and bigger the fat
cell, the more cholesterol it has been shown to contain
[8,13,47]. The rate of de novo cholesterol synthesis in adi-
pose tissue is only 4% compared to that of liver [44] and
therefore, may not contribute significantly to the circula-
tory cholesterol but current literature suggests an import-
ant role for adipose tissue in regulation of circulatory
HDL-C by mediating HDL lipidation [2,48]. Chung et al.
[2] have shown that specific deletion of cholesterol trans-
porter ABCA1 in adipose tissue significantly reduces
HDL-C levels. The increased biosynthesis in adipose tissue
therefore, may interfere with the lipidation process in vita-
min B12-restricted conditions. The aim of this manuscript
is to show how specific pathways could be regulated by
vitamin B12 and provide a direct mechanism through
its role in regulating AdoMet levels. Further, in vivo
studies are required to measure contribution of
adipose tissue in circulatory cholesterol, particularly
under vitamin B12-deficient conditions.
Conclusions
In conclusion, the vitamin B12 plays an important role in
the adipocyte metabolism and its deficiency led to in-
creased homocysteine and total cholesterol. This is one
of the first studies providing a direct mechanism by
which vitamin B12 may be regulating wider metabolic
changes, particularly in states of deficiency. Our findings
highlight the importance of adequate levels of vitamin
B12 during the periconceptional period and the relevance
to groups prone to deficiency such as vegetarians and
vegans. There may also be a case for how we diagnose
vitamin B12 deficiency which can be improved by meas-
urement of the active plasma fraction of transcobalamin
(holo-TC) [49], based on our in vitro observations where
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vere compared to clinical observations. Understanding
the complete mechanisms of the role of vitamin B12 on
other tissue systems will likely provide further insights
on metabolic programming.
Methods
Clinical cohorts
Data from two independent clinical cohorts was used.
NDNS cohort
NDNS survey was conducted between July 2000 and
June 2001, in a nationwide representative sample of
3,704 patients across the country. Of these, 1,256 sub-
jects had full biochemical analysis which included lipid
profiles, B12, folic acid, and homocysteine and were used
for the analysis
Saudi pregnant women cohort
This cohort consisted of 152 pregnant women living
in Riyadh, KSA, who participated in an observational
study designed to assess the vitamin B12, folate, and
homocysteine status during pregnancy. Pregnant
women attending the antenatal clinics, primary health
clinics, and the Prince Salman Bin Abdulaziz Hospital
in the western health sector in Riyadh were recruited.
Participating subjects were asked to fast before their
visit to be enrolled in the study. Women aged 18 to
40 years, non-smokers, with pre-pregnancy BMI > 17
and <37 kg/m2, without any significant medical prob-
lems, and not under any medication were eligible for
the study. Women were excluded if they were anemic,
on multivitamins, or had any nutrition-related pre-
existing medical condition such as coeliac disease,
known diabetes or any liver, cardiac, or kidney dis-
eases. The data collection was carried out from May
2009 to December 2010 from pregnant women at the
second trimester; between 16 and 28 weeks gestation.
University Hospital Coventry and Warwickshire (UHCW)
cohort and adipose tissue collection
Women with singleton pregnancy undergoing elective
caesarean section at term (37 to 42 weeks of gestation)
were recruited after written informed consent (UHCW
cohort). Women with known chronic diseases were ex-
cluded. Maternal anthropologic measures, data including
parity, smoking, diet, and vitamin use were collected.
Paired maternal venous blood samples (n = 91) and adi-
pose tissue (subcutaneous) were collected at the time of
caesarean section. Fasting maternal blood and cord
blood samples collected in tubes without anticoagulant
were centrifuged at 2,000 rpm/10 min. Serum was sepa-
rated, aliquoted, and stored at −80°C until analysis. All
tissue samples were flash frozen and/or utilized forcharacterizing gene expression and protein expression
by RNA isolation and protein extraction, respectively.
The study was approved by the NHS Research Ethics
Committee (07/H1210/141).Culture and differentiation of human pre-adipocytes
Human preadipocyte cell line Chub-S7 [50] and
human primary preadipocytes were cultured and
differentiated as described elsewhere [51]. Briefly, the
preadipocytes were grown to confluence in customised
growth media (GM). At confluence (day 0), preadipo-
cytes were differentiated in differentiation media (DM)
for 72 h (day 03) and were maintained in nutrition
media (NM) thereafter for 11 days (day 14). The day
differentiation was initiated (at confluence) was con-
sidered as day 0. On day 14, conditioned media were
collected and cells were harvested for protein and
RNA analysis and stored at −80°C until use. Primary
human preadipocytes were isolated from human ab-
dominal subcutaneous (AbSc) AT, collected from pa-
tients (age: 40.8 ± 5 years; lean BMI: 22.04 ± 2.6 kg/m2)
undergoing surgery with informed consent obtained
in accordance with LREC guidelines and with ethics
committee approval.
The DMEM/F-12 medium used above was customised
initially for 12 different B12 and folic acid concentrations
(Additional file 1: Figure S1) but we will present three
main conditions as follows: (1) control: normal B12 (B12,
500 nM; folic acid, 6 μM); (2) LB: low B12 (B12, 0.15 nM;
folic acid, 6 μM); and (3) NoB: no B12 and 6 μM folic
acid. For methylation inhibition, preadipocytes were
incubated with 200 nM of 5-aza-2′-deoxycytidine
(5-Aza-dC) at 50% confluency for 72 h and were dif-
ferentiated at confluence.Isolation of RNA and quantitative real time-PCR (qRT-PCR)
analysis
The total RNA from the adipocytes was isolated using
RNeasy Lipid Tissue Kit (Qiagen, Venlo, Limburg) ac-
cording to manufacturer’s protocol. cDNA synthesis,
quantitative PCR and analysis were conducted as de-
scribed elsewhere [51]. RNA expressions were normal-
ized to the housekeeping gene 18s rRNA (Applied
Biosystems, Paisley, UK, 4319413E). The custom taqman
gene expression assays from Applied Biosystems were
used for all the genes; their catalogue numbers are
provided in brackets. The details of the gene assays are:
SREBF1 (Hs01088691_m1); SREBF2 (Hs01081784_m1);
LDLR (Hs00181192_m1); HMGCR (Hs00168352_m1);
HMGCS1 (Hs00940429_m1); IDI1 (Hs01057440_m1);
SQLE (Hs01123768_m1); SC4MOL (Hs00932159_m1);
Insig1 (Hs01650979_m1); and StarD4 (Hs00287823_m1).
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Cells were washed with ice cold phosphate-buffered sa-
line (PBS) and harvested in lysis buffer (radioimmuno-
precipitation assay (RIPA) buffer with protease and
phosphatase inhibitors) and stored at −80°C until re-
quired [51]. Extracts were quantitated by the Bradford
protein assay. Western blot analysis was performed as
described elsewhere [52].
Measurement of cholesterol and homocysteine
Total cholesterol was determined fluorimetrically in cell
lysates using Amplex Red cholesterol assay kit according
to manufacturer’s protocol (Invitrogen, Carlsbad, CA,
USA). Reduced homocysteine was chromatographically
separated using ion-paired reversed-phase HPLC with
oxidative mode electrochemical detection (ECD). Condi-
tioned media or serum was reduced with 50 mM DTT
at 37°C for 15 min, precipitated by 150 g/L sulphosa-
licylic acid and centrifuged and supernatant used for de-
tection and analysis.
DNA methylation
Genome-wide DNA methylation was performed using
Illumina HumanMethylation 450Beadchip (Illumina, San
Diego, CA, USA) on sample triplicates from the control,
LB, and no B groups. High-quality genomic DNA was
bisulphite converted using EZ-96 DNA Methylation Kit
(Zymo Research, Irvine, CA, USA) according to manu-
facturer’s protocols. Efficiency of the C-to-T bisulphite
conversion was tested using qPCR using primers to re-
gions of the MLH and GAPDH genes (see Additional file
2: Table S1). Samples showing high (>98%) conversion
efficiency were hybridised to the array. Arrays were
scanned using two-color laser scanner. Data was quantile-
normalized (per probe and per color channel). An R-based
Limma package available via Bioconductor 2.11 was used
to generate quantitative methylation values (β-values) to
identify regions of differential methylation.
Validation of the relevant regions of differential methy-
lation was performed using bisulphite-pyrosequencing, a
quantitative assay of DNA methylation with single base
pair resolution. Bisulphite converted DNA was amplified
using primers designed to the relevant target regions
(see Additional file 2: Methods) and pyrosequencing per-
formed using Qiagen PyroMark software and system.
AdoMet/s-adenosylhomocysteine (AdoHcy)
Measurement of intracellular AdoMet and AdoHcy were
determined by stable isotopic dilution analysis liquid
chromatography using a Waters Acquity UPLC system
with a Quattro Premier XE tandem mass spectrometric
detector (Waters Corporation, Milford, MA, USA).
Briefly, isotopic standard (AdoMet-d3/AdoHcy-d4; 2
pmol/μl) was added to the cell pellets, deproteinized by5% TCA and centrifuged at 6,000 g for 5 min at 4°C. The
supernatant was then filtered and the ultrafiltrate was
analyzed by LC-MS/MS system [53].
Measurement of 2-deoxy-D-[1-3H] glucose uptake
Cells were washed with PBS and incubated at 37°C for
3 h in KRH buffer plus 0.01% BSA and 5 mmol/L glu-
cose for insulin and serum starvation. Then, adipocytes
were pre-incubated for 30 min at 37°C with KRH buffer
without glucose with insulin, 1 μCi of 2-deoxy-D-[1-3H]
glucose/ml was added and incubated for further 10 min.
Cells were washed with ice-cold PBS and harvested in
RIPA. Radioactivity was counted after adding scintilla-
tion fluid.
Analytical determinations for clinical study
Serum, HDL and LDL cholesterol, and triglycerides
were determined using an auto analyzer Synchron
CX7 (Beckman Coulter, Brea, CA, USA) based on
enzymatic colorimetric assays. B12 and folate were
determined by electrochemiluminescent immunoassay
using a Roche Cobas immunoassay analyzer. The ref-
erence values in our laboratory for non-pregnant
women are as follows: 191 to 663 ng/L for vitamin B12
and 4.6 to 18.7 μg/L for folate.
Statistical analysis
Laboratory data is presented as mean ± standard error of
the mean (SEM) for at least three independent experi-
ments to ensure reproducibility. Student’s t-test was
used to compare values between two groups unless
stated otherwise. P values < 0.05 were considered statisti-
cally significant. For clinical data, the biochemical pa-
rameters were log-transformed before analysis, as they
were not normally distributed. All data were presented
as mean ± standard error. No imputation was performed
for the missing data. Means of continuous variables were
compared using independent t-tests. Bivariate correlations
between different variables were done using Spearman’s
test. To assess the independent role of B12 on outcome
variables, multivariate linear regression was carried out,
adjusting for all possible confounders including age and
BMI as independent variables. Care was taken to avoid
inter-correlated variables in the regression analyses. For all
the tests, P values < 0.05 were considered to be statistically
significant. All analyses were performed using IBM SPSS
Statistics version 19.
Additional files
Additional file 1: Figure S1. Effect of B12/folic acid on total cholesterol
and homocysteine (Hcy) levels. (A) Total intracellular cholesterol from cell
lysates and (B) extracellular levels of Hcy from conditioned media
measured from the adipocytes cultured in customised media
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experiments were performed as triplicates. Values are mean ± SEM. *P ≤
0.05; **P ≤ 0.01, ***P ≤ 0.001, P value compared to control. Figure S2.
Bisulphite-pyrosequencing amplicon; (A) SREBF1 - located on chromo-
some 17,723,166-17,723,321. (B) LDLR - located on chromosome 19;
11,199,399-11,199,590. Unconverted sequence is shown. Flanking primer
sequences for the BS-pyrosequencing amplicon are marked in green
and the sequencing primer is in yellow. This region contains CpG sites
(in red and numbered in sequencing order). Figure S3. Location of
Illumina 450k probe and bisulphite pyrosequencing assay: (A) SREBF1 -
cg27407935 and (B) LDLR-cg22971501. Figure S4. Transcript variants of
(A) SREBF1 and (B) LDLR, plotted using UCSC ENCODE browser, showing
location markers for H3K27Ac, DNaseI hypersensitivity, transcription factor
binding density across ChIP-Seq experiments and CpG islands. Transcrip-
tion start sites have been added, indicated in red arrows above, and
PPARγ gamma and C/EBPα binding sites, assayed by ChIP-Seq. in human
adipocytes [32,33] indicated in red rectangles below. The sites we found
to be significantly differentially methylated are indicated by yellow stars.
Figure S5. Effect of B12 in primary adipocytes: (A) Total cholesterol was
measured fluorimetrically in cell lysates collected from the differentiated
Chub-S7 adipocytes maintained in customised media supplemented with
B12 (0, 0.15, 500 nM) and folate (6 μM) concentrations. Total cholesterol
was normalized for protein content and expressed as percentage. (B)
Homocysteine in conditioned media. Relative mRNA expression of (C)
SREBF1, (D) SREBF2, and (E) LDLR were measured from the differentiated
Chub-S7 adipocytes maintained in customised media supplemented with
B12 (0, 0.15, 500 nM) and folate (6 μM) concentrations. All experiments
were performed as triplicates. Values are mean ± SEM. *P ≤ 0.05; **P ≤
0.01, ***P ≤ 0.001, P value compared to control.
Additional file 2: Table S1. Primer Sequences for bisulphite conversion
efficiency experiments. Table S2. Bisulphite-pyrosequencing primer
design for LDLR and SREBF1. Table S3. Methylation values per CpG
within the SREBF1 amplicon measured by bisulphite-pyrosequencing.
CpG 1 (in bold) denotes the cg2747935 Illumina 450k probe showing
genome-wide significance between experimental groups. Table S4.
Methylation values per CpG within the LDLR amplicon measured by
bisulphite-pyrosequencing. CpG 2 (in bold) denotes the cg22971501
Illumina 450k probe showing genome-wide significance between
experimental groups. No data was generated from CpG 4 due to poor
sequencing efficiency. Table S5. Beta (methylation)-values at all Illumina
450k probes per experimental group located within the LDLR, SREBF1
and SREBF2 genes. The two probes where between-group methylation
difference reaches genome-wide significance (FDR-adjusted P value < 0.05)
are highlighted in yellow.
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